Eur Rev Med Pharmacol Sci 2015; 19 (23): 4488-4493

Infected bone inactivation combined with transplantation of autologous platelet-rich plasma and bone marrow for treatment of chronic osteomyelitis

J.-H. Wang, K. Zhao, H.-L. Liu, H.-M. Zhao, J. Yang, X.-K. Sun

Departments of Foot and Ankle Surgery and 2Departments of Surgery; Xi’an Hong Hui Hospital, Xi’an, China. drsunxiaoke@163.com


OBJECTIVE: Here we tested the therapeutic efficacy of infected bone inactivation combined with transplantation of autologous platelet-rich plasma and bone marrow in chronic osteomyelitis.

PATIENTS AND METHODS: 64 patients with chronic osteomyelitis were randomly divided into two groups. Patients in control group received conventional antibiotic and surgical treatments, while patients in the experimental treatment group underwent infected bone inactivation combined with transplantation of autologous platelet-rich plasma and bone marrow. The X-ray, histological, and biochemical (alkaline phosphatase) changes were assessed at 4, 8, 12 and 16 weeks after the treatment.

RESULTS: At all tested study points, X-ray and histological scores, and alkaline phosphatase levels were significantly better in patients of the experimental treatment group.

CONCLUSIONS: Infected bone inactivation combined with transplantation of autologous platelet-rich plasma and bone marrow achieves beneficial therapeutic results in chronic osteomyelitis.

Free PDF Download

To cite this article

J.-H. Wang, K. Zhao, H.-L. Liu, H.-M. Zhao, J. Yang, X.-K. Sun
Infected bone inactivation combined with transplantation of autologous platelet-rich plasma and bone marrow for treatment of chronic osteomyelitis

Eur Rev Med Pharmacol Sci
Year: 2015
Vol. 19 - N. 23
Pages: 4488-4493